Insta
WHO Temporarily Suspends Trials Of Hydroxychloroquine Against COVID-19 Citing Safety Concerns
WHO Director General Dr Tedros Adhanom Ghebreyesus
The World Health Organisation (WHO) has suspended all testing activity involving the anti-malarial drug hydroxychloroquine for the treatment of COVID-19 patients citing safety concerns, reports Hindustan Times.
The development was announced by WHO's Director-General Tedros Adhanom Ghebreyesus yesterday (25 May) in an online briefing. He, however, mentioned that the suspension was temporary by nature and that the safety data is being reviewed by the data safety monitoring board.
The concerns were also backed by the head of WHO's emergencies programme Dr Mike Ryan who underscored that the decision to suspend the solidarity trials of hydroxychloroquine has been taken by the executive group of WHO out of "an abundance of caution."
It should be noted that the drug has been touted by the United States (US)' President Donald Trump and several others as a potential treatment for COVID-19 disease. President Trump had gone as far as to assert that he was taking the drug to help prevent the disease.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
